期刊簡介 | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | AMERICAN JOURNAL OF MANAGED CARE LetPub Score 5.4
50 ratings
Rate
Reputation 6.4 Influence 3.8 Speed 9.1 | |||||||||||||||||||||
期刊簡稱 | AM J MANAG CARE | |||||||||||||||||||||
ISSN | 1088-0224 | |||||||||||||||||||||
E-ISSN | 1936-2692 | |||||||||||||||||||||
h-index | 81 | |||||||||||||||||||||
CiteScore |
| |||||||||||||||||||||
自引率 (2023-2024) | 4.00%自引率趨勢 | |||||||||||||||||||||
掲載範囲 |
| |||||||||||||||||||||
官方網站 | http://www.ajmc.com/ | |||||||||||||||||||||
在線稿件提交 | ||||||||||||||||||||||
開放訪問 | No | |||||||||||||||||||||
出版商 | Ascend Media | |||||||||||||||||||||
主題領域 | 医学 | |||||||||||||||||||||
出版國/地區 | UNITED STATES | |||||||||||||||||||||
發行頻率 | 月刊 | |||||||||||||||||||||
創刊年 | 1995 | |||||||||||||||||||||
每年文章數 | 127每年文章數趨勢 | |||||||||||||||||||||
黃金OA百分比 | 0.25% | |||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| |||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded Social Science Citation Index | |||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1088-0224%5BISSN%5D | |||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) | |||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy | |||||||||||||||||||||
參考鏈接 |
| |||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[AMERICAN JOURNAL OF MANAGED CARE] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 16:04:52 評論於 It is still necessary for us to clearly indicate the limitations of the study in the paper, and explain how these limitations affect the conclusions of the paper, so that reviewers and other readers can understand that we have fully considered the limitations of the study. Discussing the limitations of the research work in the discussion section generally increases the credibility of the article. Thinking about how to overcome these limitations in future research will have a positive effect(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:00:01 評論於 We recommend dividing the discussion of research limitations into three parts: (1) identifying research limitations; (2) explaining research limitations in detail; and (3) proposing future research directions or improvement solutions. Discussing research limitations in this order can help you clearly point out the shortcomings of the research without compromising its quality and validity(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 19:58:14 評論於 Is it necessary to clarify the limitations of the article in the discussion?(0) 讚! | 八坂篷蔚 |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 10:28:45 評論於 How to write about limitations in a discussion?(0) 讚! | 深渊兴业 |
作者: 洗髓亦梦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-18 15:06:54 評論於 Do you need a layout fee?(0) 讚! | 洗髓亦梦 |
作者: Queen 領域: 医学 審稿時間: 3.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-10-11 15:49:18 評論於 is still a very easy journal. There is no good choice to consider(0) 讚! | Queen |
作者: 妙音大叔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-10-10 10:04:07 評論於 Review speed: 3.0, experience sharing: It is still a relatively easy journal to get accepted in, but there are not many good options to consider(0) 讚! | 妙音大叔 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 21:03:51 評論於 A little bleak, can't even keep this 1.5 points, how am I going to survive??(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 11:29:51 評論於 It's a bit sad, I can't even keep this 1.5 points, how am I supposed to live??(0) 讚! | 凌霄高洁 |
作者: 无击刚豪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-09-14 13:53:06 評論於 HEALTH POLICY & SERVICES rank=5 Q1(0) 讚! | 无击刚豪 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-02-14 15:35:51 評論於 The review process is too slow, and the re-review time is always over 3 months(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us